PET Found to Be a Specific and Sensitive Tool for Diagnosis of Alzheimer's Disease

RESEARCH NEWS 2001-11-07 Research News Numerous studies have shown that positron emission tomography (PET) can reveal small metabolic changes in the brains of patients with neurodegenerative disorders, particularly Alzheimer's disease. However, the paucity of cases examined

PAPER Kim KW, Jhoo JH, Lee KU, Lee DY, Lee JH, Youn JY, Lee BJ, Han SH, Woo JI

Association between apolipoprotein E polymorphism and Alzheimer's disease in Koreans.

Neurosci Lett. 1999 Dec 31;277(3):145-8. PubMed.

PAPER Lezoualc'h F, Engert S, Berning B, Behl C

Corticotropin-releasing hormone-mediated neuroprotection against oxidative stress is associated with the increased release of non-amyloidogenic amyloid beta precursor protein and with the suppression of nuclear factor-kappaB.

Mol Endocrinol. 2000 Jan;14(1):147-59. PubMed.

PAPER Siman R, Reaume AG, Savage MJ, Trusko S, Lin YG, Scott RW, Flood DG

Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability.

J Neurosci. 2000 Dec 1;20(23):8717-26. PubMed.

PAPER García-Jiménez A, Cowburn RF, Ohm TG, Bogdanovic N, Winblad B, Fastbom J

Quantitative autoradiography of [3H]forskolin binding sites in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits.

Brain Res. 1999 Dec 11;850(1-2):104-17. PubMed.

PAPER Monk D, Brodaty H

Use of estrogens for the prevention and treatment of Alzheimer's disease.

Dement Geriatr Cogn Disord. 2000 Jan-Feb;11(1):1-10. PubMed.

PAPER Scherder EJ, Bouma A

Acute versus chronic pain experience in Alzheimer's disease. a new questionnaire.

Dement Geriatr Cogn Disord. 2000 Jan-Feb;11(1):11-6. PubMed.

PAPER Imbimbo BP, Troetel WM, Martelli P, Lucchelli F

A 6-month, double-blind, placebo-controlled trial of eptastigmine in Alzheimer's disease.

Dement Geriatr Cogn Disord. 2000 Jan-Feb;11(1):17-24. PubMed.

PAPER Licastro F, Masliah E, Pedrini S, Thal LJ

Blood levels of alpha-1-antichymotrypsin and risk factors for Alzheimer's disease: effects of gender and apolipoprotein E genotype.

Dement Geriatr Cogn Disord. 2000 Jan-Feb;11(1):25-8. PubMed.

PAPER Lehtovirta M, Partanen J, Könönen M, Hiltunen J, Helisalmi S, Hartikainen P, Riekkinen P, Soininen H

A longitudinal quantitative EEG study of Alzheimer's disease: relation to apolipoprotein E polymorphism.

Dement Geriatr Cogn Disord. 2000 Jan-Feb;11(1):29-35. PubMed.

PAPER Mosek A, Yust I, Treves TA, Vardinon N, Korczyn AD, Chapman J

Dementia and antiphospholipid antibodies.

Dement Geriatr Cogn Disord. 2000 Jan-Feb;11(1):36-8. PubMed.

PAPER Kazui H, Hashimoto M, Hirono N, Imamura T, Tanimukai S, Hanihara T, Ikeda M, Komori K, Ikejiri Y, Mori E

A study of remote memory impairment in Alzheimer's disease by using the family line test.

Dement Geriatr Cogn Disord. 2000 Jan-Feb;11(1):53-8. PubMed.

PAPER Lindahl U

What else can 'Heparin' do?

Haemostasis. 1999 Dec;29 Suppl S1:38-47. PubMed.

PAPER Greene RA

Cerebral blood flow.

Fertil Steril. 2000 Jan;73(1):143. PubMed.

PAPER Zhuo M, Holtzman DM, Li Y, Osaka H, DeMaro J, Jacquin M, Bu G

Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation.

J Neurosci. 2000 Jan 15;20(2):542-9. PubMed.